Registration Frequencies

Shown are frequencies of observation starts at registration by medication.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1009 307
Brodalumab 267
Certolizumab 88 0
Efalizumab 35 0
Etanercept 308 57
Golimumab 25 0
Guselkumab 559 0
Infliximab 101 1
Ixekizumab 452 0
Risankizumab 235 0
Secukinumab 1267 0
Tildrakizumab 307 0
Ustekinumab 702 0
Apremilast 514 0
Ciclosporin 388 0
Fumaderm 2598 0
Skilarence 1658 0
Methotrexate 3158 0
Tofacitinib 1 0
other systemics 327 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers